BIOMARKERS FOR TREATMENT WITH ANTI-TUBULIN CHEMOTHERAPEUTIC COMPOUNDS
- 专利权人:
- 发明人:
- Ingrid Wertz
- 申请号：
- US14322065
- 公开号：
- US20160136295A1
- 申请日:
- 2014.07.02
- 申请国别(地区):
- US
- 年份:
- 2016
- 代理人:
- 摘要：
- Provided herein are biomarkers for predicting sensitivity to treating cancer with anti-tubulin chemotherapeutic agents.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- USE OF GLU-tubulin as a biomarker of PHARMACEUTICAL RESPONSE TO FURAZANOBENZIMIDAZOLER
- BIOMARKERS AND METHODS TO PREDICT RESPONSE TO INHIBITORS AND USES THEREOF
- BIOMARKERS AND METHODS TO PREDICT RESPONSE TO INHIBITORS AND USES THEREOF
- Początkowa względna liczba limfocytów jako biomarker predykcyjny
- Prediction of clinical response to IL-23 antagonists using IL-23 signal line biomarkers
